HARBIN GLORIA PHARMACEUTICALS Co., LTD (SZSE: 002437)
Health Care · Pharmaceuticals · CN
CN¥3.65
+4.29% today · +16.6% 1Y
HARBIN GLORIA PHARMACEUTICALS Co., LTD (SZSE: 002437) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.21B and employs 2,350 people.
Over the last twelve months the share price has gained 16.6%, trading between 2.37 and 5.10.
Tweenvest scores HARBIN GLORIA PHARMACEUTICALS Co., LTD across four factors: quality 75/100, value 29/100, growth 0/100. Its strongest factor is quality.
002437 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.21B
- Revenue (TTM)
- $300.76M
- P/E
- 20.22
- EPS
- 0.18
- Dividend yield
- —
- Beta (5Y)
- 0.16
- 52-week high
- CN¥5.10
- 52-week low
- CN¥2.37
- Avg volume (3M)
- —
- Shares outstanding
- 2.23B
- Employees
- 2,350
- Next earnings
- —
About HARBIN GLORIA PHARMACEUTICALS Co., LTD
Harbin Gloria Pharmaceuticals Co., Ltd. is a Chinese pharmaceutical enterprise primarily focused on the research, development, manufacturing, and commercialization of various medicinal products within the People's Republic of China. The company's comprehensive portfolio addresses a broad spectrum of therapeutic areas, including cardiac and cerebrovascular health, skeletal muscle system support, and urinary tract conditions. It also provides vitamins and minerals, as well as medications for oncology, endocrine disorders, anti-infective treatments, respiratory ailments, antihistamine purposes, and peptic concerns, among other pharmaceutical goods. Established in 2000, the firm's headquarters are located in Harbin, also situated in the People's Republic of China.
- ISIN
- CNE100000QG8
- Founded
- 2000
- Listed since
- Oct 27, 2011
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shandong Xinhua Pharmaceutical Company LimitedSEHK: 719 | $1.24B | HK$5.80 | +0.52% |
| Jiangsu Yahong Meditech Co., Ltd.SHSE: 688176 | $1.23B | CN¥14.60 | -0.88% |
| Changzhou Qianhong Biopharma CO.,LTDSZSE: 002550 | $1.23B | CN¥6.59 | +3.62% |
| Shandong Lukang Pharmaceutical Co.,Ltd.SHSE: 600789 | $1.22B | CN¥7.85 | +4.11% |
| Aurisco Pharmaceutical Co.,Ltd.SHSE: 605116 | $1.21B | CN¥20.07 | +2.40% |
| Shanghai Yizhong Pharmaceutical Co., Ltd.SHSE: 688091 | $1.20B | CN¥39.40 | -1.38% |
| Sichuan Huiyu Pharmaceutical Co., Ltd.SHSE: 688553 | $1.19B | CN¥12.85 | +4.81% |
| LB Pharmaceuticals IncNasdaqGM: LBRX | $1.19B | $34.61 | -6.43% |
Figures last refreshed Oct 4, 2026.